The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Nipun Merchant joins Sylvester Comprehensive Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

NIPUN MERCHANT is joining the Sylvester Comprehensive Cancer Center as chief surgical officer and director of Surgical Oncology Research Programs.

Merchant will also take on the newly created position of vice chair of Surgical Oncologic Services and Academic Affairs within the Department of Surgery, and will be the chief of Surgical Oncology at University of Miami Hospital as well as chief surgical officer at UMHC/Sylvester. In addition, he will serve as chief of the Division of Surgical Oncology.

He comes to the University of Miami from Vanderbilt University Medical Center, where he has been the director of the Vanderbilt Pancreas Center, chief of GI Surgical Oncology and co-leader of the GI Oncology Program at Vanderbilt-Ingram Comprehensive Cancer Center.

As vice chair, he will lead the clinical and research enterprises of surgical oncology and oversee the educational and academic programs. Merchant’s clinical practice is in GI malignancies with a focus on hepatobiliary and pancreatic cancers.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Sponsored

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.
By The American Society of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account